
@article{ WOS:000396288600001,
Author = {Lei, Yong and Yi, Yanhua and Liu, Yang and Liu, Xia and Keller, Evan T.
   and Qian, Chao-Nan and Zhang, Jian and Lu, Yi},
Title = {Metformin targets multiple signaling pathways in cancer},
Journal = {CHINESE JOURNAL OF CANCER},
Year = {2017},
Volume = {36},
Month = {JAN 26},
Abstract = {Metformin, an inexpensive and well-tolerated oral agent commonly used in
   the first-line treatment of type 2 diabetes, has become the focus of
   intense research as a candidate anticancer agent. Here, we discuss the
   potential of metformin in cancer therapeutics, particularly its
   functions in multiple signaling pathways, including AMP-activated
   protein kinase, mammalian target of rapamycin, insulin-like growth
   factor, c-Jun N-terminal kinase/mitogen-activated protein kinase (p38
   MAPK), human epidermal growth factor receptor-2, and nuclear factor
   kappaB pathways. In addition, cutting-edge targeting of cancer stem
   cells by metformin is summarized.},
Publisher = {SUN YAT SEN UNIV MED SCI WHO},
Address = {651 DONGFENG RD E, GUANGZHOU, GUANGDONG 510060, PEOPLES R CHINA},
Type = {Review},
Language = {English},
Affiliation = {Zhang, J; Lu, Y (Corresponding Author), Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China.
   Zhang, J; Lu, Y (Corresponding Author), Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China.
   Zhang, J (Corresponding Author), Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA.
   Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Minist Educ, Key Lab Longev \& Ageing Related Dis, Nanning 530021, Guangxi, Peoples R China.
   Lei, Yong; Liu, Yang; Liu, Xia; Zhang, Jian; Lu, Yi, Guangxi Med Univ, Ctr Translat Med, 14th Floor,Pharmacol \& Biomed Sci Bldg, Nanning 530021, Guangxi, Peoples R China.
   Yi, Yanhua, Guangxi Med Univ, Sch Int Educ, Nanning 530021, Guangxi, Peoples R China.
   Keller, Evan T.; Zhang, Jian, Univ Michigan, Sch Med, Dept Urol \& Pathol, Ann Arbor, MI 48109 USA.
   Qian, Chao-Nan, Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Collaborat Innovat Ctr Canc Med,State Key Lab Onc, Guangzhou 510060, Guangdong, Peoples R China.},
DOI = {10.1186/s40880-017-0184-9},
Article-Number = {17},
ISSN = {1000-467X},
EISSN = {1944-446X},
Keywords = {Metformin; Signaling pathway; Cancer stem cell; Cancer},
Keywords-Plus = {ANTIDIABETIC DRUG METFORMIN; NF-KAPPA-B; EPITHELIAL-MESENCHYMAL
   TRANSITION; BREAST-CANCER; STEM-CELLS; PANCREATIC-CANCER; IN-VITRO;
   PROSTATE-CANCER; MTOR PATHWAY; IGF-I},
Research-Areas = {Oncology},
Web-of-Science-Categories  = {Oncology},
Author-Email = {jianzhang008@hotmail.com
   luyi5555@hotmail.com},
Affiliations = {Guangxi Medical University; Guangxi Medical University; University of
   Michigan System; University of Michigan; Sun Yat Sen University},
ResearcherID-Numbers = {Keller, Evan T/M-1446-2016
   ZHANG, JIAN/Q-6334-2018
   Lu, Yi/J-6746-2018
   },
ORCID-Numbers = {Keller, Evan T/0000-0002-7592-7535
   Yi, Yanhua/0000-0001-8690-952X},
Funding-Acknowledgement = {National Natural Science Foundation of China (NSFC) Key Project
   {[}81130046]; NSFC {[}81171993, 81272415]; Guangxi Key Projects
   {[}2013GXNSFEA053004]; Guangxi Projects {[}1355004-5,
   2012GXNSFCB053004]; Guangxi Ministry of Education {[}201202ZD022,
   201201ZD004]},
Funding-Text = {This work was supported by National Natural Science Foundation of China
   (NSFC) Key Project 81130046 (to JZ); NSFC81171993 (to YL) and
   NSFC81272415 (to YL); Guangxi Key Projects 2013GXNSFEA053004 (to JZ);
   Guangxi Projects 1355004-5 (to JZ) and 2012GXNSFCB053004 (to YL);
   Guangxi Ministry of Education 201202ZD022 (to YL) and 201201ZD004 (to
   JZ). The authors thank Ms. Xin Huang and Ms. Xiaolin Zhou for editing.},
Cited-References = {Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003.
   Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483.
   Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252.
   Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933.
   Alvero AB, 2009, CELL CYCLE, V8, P158, DOI 10.4161/cc.8.1.7533.
   Arai M, 2010, J PHARMACOL EXP THER, V334, P206, DOI 10.1124/jpet.109.164970.
   Bao B, 2012, CANCER PREV RES, V5, P355, DOI 10.1158/1940-6207.CAPR-11-0299.
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236.
   Barrière G, 2013, ANTI-CANCER AGENT ME, V13, P333, DOI 10.2174/1871520611313020018.
   Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487.
   Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419.
   Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024.
   Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769.
   Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186.
   Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859.
   Cazzaniga M, 2009, CANCER EPIDEM BIOMAR, V18, P701, DOI 10.1158/1055-9965.EPI-08-0871.
   Chaudhary SC, 2012, PHOTOCHEM PHOTOBIOL, V88, P1149, DOI 10.1111/j.1751-1097.2012.01165.x.
   Cheaib B, 2015, CHIN J CANCER, V34, P4, DOI 10.5732/cjc.014.10289.
   Checkley LA, 2014, CANCER PREV RES, V7, P54, DOI 10.1158/1940-6207.CAPR-13-0110.
   Cho SW, 2014, MOL CELL ENDOCRINOL, V393, P24, DOI 10.1016/j.mce.2014.05.021.
   Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004.
   Colquhoun AJ, 2012, PROSTATE CANCER P D, V15, P346, DOI 10.1038/pcan.2012.16.
   Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854.
   Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21.
   Deng XS, 2012, CELL CYCLE, V11, P367, DOI 10.4161/cc.11.2.18813.
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310.
   Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33.
   Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178.
   Escarcega RO, 2007, CLIN ONCOL-UK, V19, P154, DOI 10.1016/j.clon.2006.11.013.
   Fasih A, 2014, RADIAT RES, V182, P50, DOI 10.1667/RR13568.1.
   Feng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.59.
   Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030.
   Gonzalez-Angulo AM, 2010, CLIN CANCER RES, V16, P1695, DOI 10.1158/1078-0432.CCR-09-1805.
   Gou SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063969.
   Green AS, 2010, BLOOD, V116, P4262, DOI 10.1182/blood-2010-02-269837.
   Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269.
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003.
   Han G, 2015, CANCER BIOL THER, V16, P77, DOI 10.4161/15384047.2014.987021.
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249.
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704.
   Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110.
   Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994.
   Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024.
   Honjo S, 2014, INT J ONCOL, V45, P567, DOI 10.3892/ijo.2014.2450.
   HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165.
   Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x.
   Iliopoulos D, 2011, CANCER RES, V71, P3196, DOI 10.1158/0008-5472.CAN-10-3471.
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494.
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2.
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682.
   Jones RA, 2007, ONCOGENE, V26, P1636, DOI 10.1038/sj.onc.1209955.
   Jung M, 2001, SEMIN RADIAT ONCOL, V11, P346, DOI 10.1053/srao.2001.26034.
   Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014.
   Karnevi E, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-235.
   Kim HG, 2011, BRIT J PHARMACOL, V162, P1096, DOI 10.1111/j.1476-5381.2010.01101.x.
   Kisfalvi K, 2009, CANCER RES, V69, P6539, DOI 10.1158/0008-5472.CAN-09-0418.
   Klubo-Gwiezdzinska J, 2012, ENDOCR-RELAT CANCER, V19, P447, DOI 10.1530/ERC-12-0046.
   Klümpen HJ, 2010, ONCOLOGIST, V15, P1262, DOI 10.1634/theoncologist.2010-0196.
   Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807.
   Lengyel E, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.10.026.
   Li L, 2014, CLIN CANCER RES, V20, P2714, DOI 10.1158/1078-0432.CCR-13-2613.
   Li X, 2011, J INT MED RES, V39, P358, DOI 10.1177/147323001103900203.
   Liu BL, 2009, CELL CYCLE, V8, P2031, DOI 10.4161/cc.8.13.8814.
   Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7.
   Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200.
   Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811.
   Malaguarnera R, 2014, ENDOCRINOLOGY, V155, P1207, DOI 10.1210/en.2013-1925.
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009.
   McCampbell AS, 2006, CLIN CANCER RES, V12, P6373, DOI 10.1158/1078-0432.CCR-06-0912.
   McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001.
   Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055.
   Memmott RM, 2009, J CLIN ONCOL, V27, pE226, DOI 10.1200/JCO.2009.25.3963.
   Mohammed A, 2013, TRANSL ONCOL, V6, P649, DOI 10.1593/tlo.13556.
   Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI {[}10.2217/nnm.11.61, 10.2217/NNM.11.61].
   Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777.
   Muaddi H, 2013, RADIOTHER ONCOL, V108, P446, DOI 10.1016/j.radonc.2013.06.014.
   Nahta R, 2010, CLIN BREAST CANCER, V10, pS72, DOI 10.3816/CBC.2010.s.015.
   Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369.
   Niehr F, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-76.
   Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474.
   Pan JX, 2012, CELL CYCLE, V11, P2314, DOI 10.4161/cc.20770.
   Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539.
   Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495.
   Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536.
   Qu C, 2014, MOL CELL BIOCHEM, V386, P63, DOI 10.1007/s11010-013-1845-x.
   Queiroz EAIF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098207.
   Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T.
   Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221.
   Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167.
   Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243.
   Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229.
   Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088.
   Sharma A, 2006, CANCER RES, V66, P8200, DOI 10.1158/0008-5472.CAN-06-0809.
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869.
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781.
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007.
   Sheri A, 2010, CLIN BREAST CANCER, V10, pS79, DOI 10.3816/CBC.2010.s.016.
   Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13.
   Song CW, 2012, SCI REP-UK, V2, DOI 10.1038/srep00362.
   Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86.
   Tseng SC, 2013, BIOCHEM PHARMACOL, V85, P583, DOI 10.1016/j.bcp.2012.12.001.
   Uehara T, 2015, ONCOL REP, V33, P744, DOI 10.3892/or.2014.3611.
   Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783.
   Vazquez-Martin A, 2009, ANN ONCOL, V20, P592, DOI 10.1093/annonc/mdn758.
   Vazquez-Martin A, ONCOL REP.
   Vazquez-Martin A, 2011, BREAST CANCER RES TR, V126, P355, DOI 10.1007/s10549-010-0924-x.
   Vazquez-Martin A, 2009, CELL CYCLE, V8, P788, DOI 10.4161/cc.8.5.7787.
   Vazquez-Martin A, 2009, CELL CYCLE, V8, P88, DOI 10.4161/cc.8.1.7499.
   Vitale-Cross L, 2012, CANCER PREV RES, V5, P562, DOI 10.1158/1940-6207.CAPR-11-0502.
   Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055587.
   Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410.
   Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI14178.
   Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo\_2011\_06\_482.
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016.
   Xu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1178, DOI 10.1159/000354517.
   Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021.
   Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6.
   Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500.
   Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9.
   Zhang Q, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.008.
   Zhang YM, 2014, ONCOTARGET, V5, P12936, DOI 10.18632/oncotarget.2683.
   Zhao D, 2015, INT J CANCER, V136, P2556, DOI 10.1002/ijc.29305.
   Zheng LY, 2013, CLIN CANCER RES, V19, P5372, DOI 10.1158/1078-0432.CCR-13-0203.
   Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137.
   Zhou W, 2013, CHIN J CANCER, V32, P427, DOI 10.5732/cjc.013.10086.
   Zi FM, 2014, CANC LETT B, V356, P443.
   Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025.
   Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023.},
Number-of-Cited-References = {128},
Times-Cited = {107},
Usage-Count-Last-180-days = {1},
Usage-Count-Since-2013 = {29},
Journal-ISO = {Chin. J. Cancer},
Doc-Delivery-Number = {EN8ZL},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000396288600001},
OA = {Green Published, gold},
DA = {2024-09-05},
}
